DG
AVNS

Davidson & Garrard’s Avanos Medical AVNS Stock Holding History

Davidson & Garrard’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9,400
Closed -$314K – 178
2015
Q4 		$314K Sell
9,400
-8,400
-47% -$261K 0.08% 151
2015
Q3 		$506K Buy
17,800
+3,700
+26% +$129K 0.13% 134
2015
Q2 		$571K Buy
14,100
+2,000
+17% +$89.8K 0.13% 138
2015
Q1 		$595K Buy
+12,100
New +$561K 0.14% 137

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

Davidson & Garrard's AVNS Position: Q1 2016 in Review

Davidson & Garrard sold out of Avanos Medical (AVNS) in Q1 2016, closing a stake of 9,400 shares — an estimated $314K sold.

Davidson & Garrard first reported a position in AVNS in Q1 2015 and held it in 4 quarters. The position peaked at $595K in Q1 2015. 333 funds tracked by Wall St. Rank hold AVNS as of Q1 2016.

  • Davidson & Garrard reported no remaining Avanos Medical position as of Q1 2016 after selling out during the quarter.
  • Davidson & Garrard sold 9,400 Avanos Medical shares in Q1 2016, an estimated $314K.
  • Davidson & Garrard first reported a position in Avanos Medical in Q1 2015 and held it in 4 quarters.
  • Davidson & Garrard's Avanos Medical position peaked at $595K in Q1 2015.
  • 333 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2016.

Based on Davidson & Garrard's 13F filing for Q1 2016, filed 5 May 2016.